Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Flumazenil | HCID 3373 | — |
| Reactant | Cyclopropanemethanol | HCID 75644 | — |
| Catalyst | Titanium(IV)ethoxide | HCID 2724286 | — |
| Solvent | Potassium Fluoride | HCID 522689 | — |
| Product | HCID 20434818 | HCID 20434818 | — |
Reaction Steps
A mixture of 5 g (16.5 mmol) of ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, 1.8 g (8 mmol) of tetraethyl orthotitanate and 16.5 g (230 mmol) of hydroxymethyl-cyclopropane is stirred at 110° overnight, evaporated to dryness, the residue is taken up in methylene chloride and the solution obtained is stirred for 0.5 hour with 50 ml of a saturated potassium fluoride solution. The emulsion obtained is filtered through siliceous earth, the separated organic phase is washed with water, dried over magnesium sulphate and evaporated. By crystallization from ethyl acetate there is obtained cyclopropylmethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate of melting point 156-157°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04489003 |
|---|
| Source dataset | uspto-grants-1984_12 |
|---|
| ORD ID | ord-668efbf55c8b4a9d99a36944498bb161 |
|---|
| Source note | uspto-grants-1984_12 |
|---|